Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Feb 25 | MSCI MSCI | Common Stock | Buy | Acquire P | No | No | 575.66 | 100 | 57.57 k | 1,269,951 |
24 Feb 25 | MSCI MSCI | Common Stock | Buy | Acquire P | No | No | 574.98 | 4,700 | 2.70 mm | 1,269,851 |
24 Feb 25 | MSCI MSCI | Common Stock | Buy | Acquire P | No | No | 569.86 | 500 | 284.93 k | 1,265,151 |
6 Feb 25 | MSCI MSCI | Common Stock | Payment of exercise | Dispose F | No | No | 587.48 | 32,279 | 18.96 mm | 1,264,651 |
6 Feb 25 | MSCI MSCI | Common Stock | Grant | Acquire A | No | No | 0 | 58,370 | 0.00 | 1,296,930 |
31 Jan 25 | MSCI MSCI | Premium option to purchase common stock Common Stock | Grant | Acquire A | No | No | 1200 | 44,920 | 53.90 mm | 44,920 |
31 Jan 25 | MSCI MSCI | Premium option to purchase common stock Common Stock | Grant | Acquire A | No | No | 1100 | 40,780 | 44.86 mm | 40,780 |
31 Jan 25 | MSCI MSCI | Premium option to purchase common stock Common Stock | Grant | Acquire A | No | No | 1000 | 36,846 | 36.85 mm | 36,846 |
27 Jan 25 | MSCI MSCI | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 549.83 | 29,564 | 16.26 mm | 29,564 |
31 Dec 24 | RPRX Royalty Pharma | Class A Ordinary Shares | Grant | Acquire A | No | No | 24.9416 | 1,503 | 37.49 k | 55,505 |